As Introduced
El texto subrayado se agregaría a la ley vigente. El texto tachado se eliminaría.
Skip to main content
Kansas Legislature
kslegislature.gov
menu
Home
House
account_balanceAbout the House
groupsRepresentatives
campaignEvents
chairSeating Chart
auto_storiesJournals & Calendars
manage_accountsChief Clerk of the House
gavelRules
Senate
account_balanceAbout the Senate
groupsSenators
campaignEvents
assignment_indAppointments
chairSeating Chart
auto_storiesJournals & Calendars
manage_accountsSecretary of the Senate
gavelRules
Committees
groupsCommittees
eventHearing Schedule
handshakeConference Committee Schedule
Measures & Laws
gavelAll Measures
account_balanceHouse Measures
account_balanceSenate Measures
account_balanceVotes
topicSubject Index
summarizeReports
menu_bookStatutes
schoolHow a Bill Becomes Law
menu_bookLegislative Procedure Manual
Today
campaignLive Floor Activity
videocamHouse Video
videocamSenate Video
live_tvStatehouse Live & Archive
smart_displayYouTube Channel
Resources
Archive
Search
description
Go to bill or resolution
arrow_forward
A−
A+
search
Search bills, resolutions, and statutes
help
U.S. United States department of justice, drug 7enforcement administration.8(k) "Deliver" or "delivery" means the actual, constructive or 9attempted transfer from one person to another of a controlled substance, 10whether or not there is an agency relationship.11(l) "Dispense" means to deliver a controlled substance to an ultimate 12user or research subject by or pursuant to the lawful order of a practitioner, 13including the packaging, labeling or compounding necessary to prepare the 14substance for that delivery, or pursuant to the prescription of a mid-level 15practitioner.16(m) "Dispenser" means a practitioner or pharmacist who dispenses, or 17a physician assistant who has authority to dispense prescription-only drugs 18in accordance with K.S.A. 65-28a08(b), and amendments thereto.19(n) "Distribute" means to deliver other than by administering or 20dispensing a controlled substance.21(o) "Distributor" means a person who distributes.22(p) (1) "Drug" means substances:23(A) Substances Recognized as drugs in the official United States 24pharmacopeia, official homeopathic pharmacopoeia of the United States or 25official national formulary or any supplement to any of them;26(B) substances intended for use in the diagnosis, cure, mitigation, 27treatment or prevention of disease in human or animals;28(C) substances (other than food) intended to affect the structure or 29any function of the body of human or animals; and30(D) substances intended for use as a component of any article 31specified in subparagraph (A), (B) or (C).32(2) "Drug" does not include devices or their components, parts or 33accessories.34(q) "Immediate precursor" means a substance that the board has 35found to be and by rule and regulation designates as being the principal 36compound commonly used or produced primarily for use and that is an 37immediate chemical intermediary used or likely to be used in the 38manufacture of a controlled substance, the control of which is necessary to 39prevent, curtail or limit manufacture.40(r) "Electronic prescription" means an electronically prepared 41prescription that is authorized and transmitted from the prescriber to the 42pharmacy by means of electronic transmission.43(s) "Electronic prescription application" means software that is used 1to create electronic prescriptions and that is intended to be installed on the 2prescriber's computers and servers where access and records are controlled 3by the prescriber.4(t) "Electronic signature" means a confidential personalized digital 5key, code, number or other method for secure electronic data transmissions 6that identifies a particular person as the source of the message, 7authenticates the signatory of the message and indicates the person's 8approval of the information contained in the transmission.9(u) "Electronic transmission" means the transmission of an electronic 10prescription, formatted as an electronic data file, from a prescriber's 11electronic prescription application to a pharmacy's computer, where the 12data file is imported into the pharmacy prescription application.13(v) "Electronically prepared prescription" means a prescription that is 14generated using an electronic prescription application.15(w) "Facsimile transmission" or "fax transmission" means the 16transmission of a digital image of a prescription from the prescriber or the 17prescriber's agent to the pharmacy. "Facsimile transmission" includes, but 18is not limited to, transmission of a written prescription between the 19prescriber's fax machine and the pharmacy's fax machine; transmission of 20an electronically prepared prescription from the prescriber's electronic 21prescription application to the pharmacy's fax machine, computer or 22printer; or transmission of an electronically prepared prescription from the 23prescriber's fax machine to the pharmacy's fax machine, computer or 24printer.25(x) "Intermediary" means any technology system that receives and 26transmits an electronic prescription between the prescriber and the 27pharmacy.28(y) "Isomer" means all enantiomers and diastereomers.29(z) "Manufacture" means the production, preparation, propagation, 30compounding, conversion or processing of a controlled substance either 31directly or indirectly or by extraction from substances of natural origin or 32independently by means of chemical synthesis or by a combination of 33extraction and chemical synthesis and includes any packaging or 34repackaging of the substance or labeling or relabeling of its container, 35except that this term does not include the preparation or compounding of a 36controlled substance by an individual for the individual's own lawful use 37or the preparation, compounding, packaging or labeling of a controlled 38substance:39(1) By a practitioner or the practitioner's agent pursuant to a lawful 40order of a practitioner as an incident to the practitioner's administering or 41dispensing of a controlled substance in the course of the practitioner's 42professional practice; or43(2) by a practitioner or by the practitioner's authorized agent under 1such practitioner's supervision for the purpose of or as an incident to 2research, teaching or chemical analysis or by a pharmacist or medical care 3facility as an incident to dispensing of a controlled substance.4(aa) "Marijuana" means all parts of all varieties of the plant Cannabis 5whether growing or not, the seeds thereof, the resin extracted from any 6part of the plant and every compound, manufacture, salt, derivative, 7mixture or preparation of the plant, its seeds or resin. It does not include:8(1) The mature stalks of the plant, fiber produced from the stalks, oil 9or cake made from the seeds of the plant, any other compound, 10manufacture, salt, derivative, mixture or preparation of the mature stalks, 11except the resin extracted therefrom, fiber, oil or cake or the sterilized seed 12of the plant that is incapable of germination;13(2) any substance listed in schedules II through V of the uniform 14controlled substances act;15(3) drug products approved by the United States food and drug 16administration as of the effective date of this act;17(4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-182-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or19(5) industrial hemp as defined in K.S.A. 2-3901, and amendments 20thereto, when cultivated, produced, possessed or used for activities 21authorized by the commercial industrial hemp act.22(bb) "Medical care facility" shall have the meaning ascribed to that 23term means the same as defined in K.S.A. 65-425, and amendments 24thereto.25(cc) "Mid-level practitioner" means a certified nurse-midwife 26engaging in the independent practice of midwifery under the independent 27practice of midwifery act, an advanced practice registered nurse issued a 28license pursuant to K.S.A. 65-1131, and amendments thereto, who has 29authority to prescribe drugs pursuant to a written protocol with a 30responsible physician under K.S.A. 65-1130, and amendments thereto, or a 31physician assistant licensed under the physician assistant licensure act who 32has authority to prescribe drugs pursuant to a written agreement with a 33supervising physician under K.S.A. 65-28a08, and amendments thereto.34(dd) "Narcotic drug" means any of the following whether produced 35directly or indirectly by extraction from substances of vegetable origin or 36independently by means of chemical synthesis or by a combination of 37extraction and chemical synthesis:38(1) Opium and opiate and any salt, compound, derivative or 39preparation of opium or opiate;40(2) any salt, compound, isomer, derivative or preparation thereof that 41is chemically equivalent or identical with any of the substances referred to 42in paragraph (1) but not including the isoquinoline alkaloids of opium;43(3) opium poppy and poppy straw; or1(4) coca leaves and any salt, compound, derivative or preparation of 2coca leaves, and any salt, compound, isomer, derivative or preparation 3thereof that is chemically equivalent or identical with any of these 4substances, but not including decocainized coca leaves or extractions of 5coca leaves that do not contain cocaine or ecgonine.6(ee) "Opiate" means any substance having an addiction-forming or 7addiction-sustaining liability similar to morphine or being capable of 8conversion into a drug having addiction-forming or addiction-sustaining 9liability. It does not include, unless specifically designated as controlled 10under K.S.A. 65-4102, and amendments thereto, the dextrorotatory isomer 11of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). It does 12include its racemic and levorotatory forms.13(ff) "Opium poppy" means the plant of the species Papaver 14somniferum l. except its seeds.15(gg) "Person" means an individual, corporation, government, or 16governmental subdivision or agency, business trust, estate, trust, 17partnership or association or any other legal entity.18(hh) "Pharmacist" means any natural person licensed under K.S.A. 1965-1625 et seq., and amendments thereto, to practice pharmacy.20(ii) "Pharmacist intern" means: (1) A student currently enrolled in an 21accredited pharmacy program; (2) a graduate of an accredited pharmacy 22program serving such person's internship; or (3) a graduate of a pharmacy 23program located outside of the United States that is not accredited and who 24had successfully passed equivalency examinations approved by the board.25(jj) "Pharmacy prescription application" means software that is used 26to process prescription information, is installed on a pharmacy's computers 27and servers, and is controlled by the pharmacy.28(kk) "Poppy straw" means all parts, except the seeds, of the opium 29poppy, after mowing.30(ll) "Practitioner" means a person licensed to practice medicine and 31surgery, dentist, podiatrist, veterinarian, optometrist, naturopathic doctor 32or scientific investigator or other person authorized by law to use a 33controlled substance in teaching or chemical analysis or to conduct 34research with respect to a controlled substance.35(mm) "Prescriber" means a practitioner or a mid-level practitioner.36(nn) "Production" includes the manufacture, planting, cultivation, 37growing or harvesting of a controlled substance.38(oo) "Readily retrievable" means that records kept by automatic data 39processing applications or other electronic or mechanized recordkeeping 40systems can be separated out from all other records within a reasonable 41time not to exceed 48 hours of a request from the board or other authorized 42agent or that hard-copy records are kept on which certain items are 43asterisked, redlined or in some other manner visually identifiable apart 1from other items appearing on the records.2(pp) "Ultimate user" means a person who lawfully possesses a 3controlled substance for such person's own use or for the use of a member 4of such person's household or for administering to an animal owned by 5such person or by a member of such person's household.6Sec. 8. K.S.A. 65-7201 is hereby amended to read as follows: 65-77201. K.S.A. 65-7201 to through 65-7218, inclusive and amendments 8thereto, and sections 1 through 5, and amendments thereto, shall be known 9and may be cited as the naturopathic doctor licensure act.10Sec. 9. K.S.A. 2022 Supp. 65-7202 is hereby amended to read as 11follows: 65-7202. As used in K.S.A. 65-7201 through 65-7218, and 12amendments thereto the naturopathic doctor licensure act:13(a) "Naturopathic doctor" means a doctor of naturopathic medicine 14who is authorized and licensed pursuant to this act.15(b) (1) "Naturopathic medicine," or "naturopathy" means a system of 16health care practiced by naturopathic doctors for the prevention, diagnosis 17and treatment of human health conditions, injuries and diseases, that uses 18education, natural medicines and therapies to support and stimulate the 19individual's intrinsic self-healing processes, and includes: (A) Prescribing, 20recommending or administering: (i) Food, food extracts, vitamins, 21minerals, enzymes, whole gland thyroid, botanicals, homeopathic 22preparations, nonprescription drugs, plant substances that are not 23designated as prescription drugs or controlled substances, topical drugs as 24defined in subsection (i); (ii) health care counseling, nutritional counseling 25and dietary therapy, naturopathic physical applications, barrier 26contraceptive devices; (iii) substances on the naturopathic formulary that 27are authorized for intramuscular or intravenous administration pursuant to 28a written protocol entered into with a physician who has entered into a 29written protocol with a naturopathic doctor licensed under the naturopathic 30doctor licensure act; (iv) noninvasive physical examinations, venipuncture 31to obtain blood for clinical laboratory tests and orofacial examinations, 32excluding endoscopies; (v) minor office procedures; and (vi) naturopathic 33acupuncture; and (B) ordering diagnostic imaging studies, including, but 34not limited to, x-ray, ultrasound, mammogram, bone densitometry, 35computed tomography, magnetic resonance imaging and 36electrocardiograms, except that naturopathic doctors shall refer patients to 37an appropriately licensed and qualified healthcare professional to conduct 38diagnostic imaging studies and interpret the results of such studies.39(2) A naturopathic doctor may not perform surgery, obstetrics, 40administer ionizing radiation, or prescribe, dispense or administer any 41controlled substances as defined in K.S.A. 65-4101, and amendments 42thereto, or any prescription-only drugs except those listed on the 43naturopathic formulary adopted by the board pursuant to this act.1(c) "Board" means the state board of healing arts.2(d) "Approved naturopathic medical college" means a college and 3program granting the degree of doctor of naturopathy or naturopathic 4medicine that has been approved by the board under this act and which 5college and program requires at a minimum a graduate-level, four-year, 6full-time resident program of academic and clinical study.7(e) "Homeopathic preparations" means substances and drugs prepared 8according to the official homeopathic pharmacopoeia recognized by the 9United States food and drug administration.10(f) "Naturopathic acupuncture" means the insertion of fine metal 11needles through the skin at specific points on or near the surface of the 12body with or without the palpation of specific points on the body and with 13or without the application of electric current or heat to the needles or skin 14or both to treat human disease and impairment and to relieve pain.15(g) "Minor office procedures" means care incidental to and treatment 16of superficial tissue, superficial lacerations and, abrasions, superficial and 17lesions and, the removal of foreign bodies located in the superficial tissues, 18except eyes, and not involving blood vessels, tendons, ligaments or nerves 19not involving the eyes, nerves, veins or arteries extending beyond 20superficial tissue. "Minor office procedures" includes use of antiseptics, 21but shall not include the topical anesthesia and local anesthesia, but does 22not include the suturing, repairing, alteration or removal of tissue or the 23use of general or spinal anesthesia. Minor office procedures does not 24include anesthetics or surgery.25(h) "Naturopathic physical applications" means the therapeutic use by 26naturopathic doctors of the actions or devices of electrical muscle 27stimulation, galvanic, diathermy, electromagnetic energy, ultrasound, 28ultraviolet light, constitutional heat, air, hot or cold hydrotherapy, 29naturopathic musculoskeletal technique and, therapeutic exercise and 30treatments taught in any approved medical college that are not otherwise 31prohibited by this act.32(i) "Topical drugs" means topical analgesics, antiseptics, scabicides, 33antifungals and antibacterials but does not include prescription only drugs.34(j) "Physician" means a person licensed to practice medicine and 35surgery.36(k) "Written protocol" means a formal written agreement between a 37naturopathic doctor licensed under this act and a person licensed to 38practice medicine and surgery. Any licensee of the board entering into a 39written protocol with a licensed naturopathic doctor shall notify the board 40in writing of such relationship by providing such information as the board 41may require.42Sec. 10. K.S.A. 65-7207 is hereby amended to read as follows: 65-437207. (a) The board shall charge and collect in advance fees provided for 1in this act as fixed by the board by rules and regulations, subject to the 2following limitations:3Application fee, not more than $2004Temporary license fee, not more than $305License renewal fee, not more than $1506License late renewal additional fee, not more than $2507License reinstatement fee, not more than $2508Certified copy of license, not more than $309Written verification of license, not more than $2510(b) The board shall charge and collect in advance fees for any 11examination administered by the board under the naturopathic doctor 12licensure act as fixed by the board by rules and regulations in an amount 13equal to the cost to the board of the examination. If the examination is not 14administered by the board, the board may require that fees paid for any 15examination under the naturopathic doctor licensure act be paid directly to 16the examination service by the person taking the examination.17Sec. 11. K.S.A. 65-7208 is hereby amended to read as follows: 65-187208. (a) The board may deny, refuse to renew, suspend, revoke, place 19under probationary conditions or limit a licensee's license or the licensee 20may be publicly or privately censured where the licensee or applicant for 21licensure has been guilty of unprofessional conduct which has endangered 22or is likely to endanger the health, welfare or safety of the public. 23Unprofessional conduct includes upon a finding that a licensee has:24(1) Obtaining Obtained a license by means of fraud, 25misrepresentation or concealment of material facts;26(2) being guilty committed an act of unprofessional conduct as 27defined by rules and regulations adopted by the board;28(3) being been convicted of a felony if the acts for which such 29person was convicted are found by the board to have a direct bearing on 30whether such person should be entrusted to serve the public in the capacity 31of a naturopathic doctor;32(4) violating violated any lawful order or rule and regulation of the 33board; and34(5) violating violated any provision of this the naturopathic doctor 35licensure act;36(6) an adverse judgment, award or settlement rendered against the 37licensee resulting from a professional liability claim related to acts or 38conduct similar to acts or conduct that would constitute grounds for 39disciplinary action under this section;40(7) failed to report to the board any adverse action taken against the 41licensee by another state or licensing jurisdiction, a healthcare facility, a 42professional association or society, a governmental agency, a law 43enforcement agency or a court for acts or conduct similar to acts or 1conduct that would constitute grounds for disciplinary action under this 2section;3(8) prescribed or administered a prescription drug or substance, 4including a controlled substance, in an improper or inappropriate manner, 5or for other than a valid medical purpose, or not in the course of the 6licensee's professional practice; and7(9) given a worthless check or stopped payment on a debit or credit 8card for fees or moneys legally due to the board.9(b) Such denial, refusal to renew, suspension, revocation, probation 10or limitation of a license or public or private censure of a licensee may be 11ordered by the board after notice and hearing on the matter in accordance 12with the provisions of the Kansas administrative procedure act. Upon the 13end of the period of time established by the board for the revocation of a 14license, application may be made to the board for reinstatement. The board 15shall have discretion to accept or reject an application for reinstatement 16and may hold a hearing to consider such reinstatement. An application for 17reinstatement of a revoked license shall be accompanied by the license 18renewal fee and the license reinstatement fee established under K.S.A. 65-197207, and amendments thereto.20(c) The board, in addition to any other penalty prescribed in 21subsection (a), may assess a civil fine, after proper notice and an 22opportunity to be heard, against a licensee for unprofessional conduct in an 23amount not to exceed $5,000 for the first violation, $10,000 for the second 24violation and $15,000 for the third violation and for each subsequent 25violation. All fines assessed and collected under this section shall be 26remitted to the state treasurer in accordance with the provisions of K.S.A. 2775-4215, and amendments thereto. Upon receipt of each such remittance, 28the state treasurer shall deposit the entire amount in the state treasury to 29the credit of the state general fund. Fines collected under this section shall 30be considered administrative fines pursuant to 11 U.S.C. § 523.31Sec. 12. K.S.A. 65-7209 is hereby amended to read as follows: 65-327209. (a) Licenses issued under this act shall expire on the date of 33expiration established by rules and regulations of the board be canceled on 34January 31 of each year unless renewed in the manner prescribed by the 35board. The request for renewal shall be accompanied by the license 36renewal fee established pursuant to K.S.A. 65-7207, and amendments 37thereto. The board may establish additional requirements for license 38renewal which that provide evidence of continued competency. The board 39shall require as a condition for renewal of a license completion of at least 4025 hours annually of continuing education approved by the board.41(b) At least 30 days before the expiration renewal date of a licensee's 42license, the board shall notify the licensee of the expiration renewal date 43by mail addressed to the licensee's last mailing address as noted upon the 1office records. If the licensee fails to submit the renewal application and 2pay the renewal fee by the date of expiration renewal date, the licensee 3shall be given a second notice that the license has expired and the license 4may be renewed only if the license licensee has failed to submit the 5renewal application and pay the renewal fee by the renewal date of the 6license and that the license will be canceled if not renewed within 30 days 7following the renewal date. The notice shall also state that if the renewal 8application, the renewal fee and the an additional late renewal fee 9established by rules and regulations are received by the board within the 10thirty-day 30-day period following the date of expiration cancellation, the 11license will not be canceled and that, if both fees are not received within 12the thirty-day 30-day period, the license shall be deemed canceled by 13operation of law without further proceedings for failure to renew and shall 14be reissued only after the license has been reinstated under subsection (c).15(c) Any license canceled for failure to renew as herein provided in 16this section may be reinstated upon recommendation of the board and 17upon, payment of the license reinstatement fee and upon submitting 18evidence of satisfactory completion of any applicable continuing education 19requirements established by the board. The board shall adopt rules and 20regulations establishing appropriate continuing education requirements for 21reinstatement of licenses canceled for failure to renew.22(d) A person whose license is suspended shall not engage in any 23conduct or activity in violation of the order or judgment by which the 24license was suspended.25Sec. 13. K.S.A. 65-7214 is hereby amended to read as follows: 65-267214. (a) There is established a naturopathic advisory council to advise the 27board in carrying out the provisions of this act. The council shall consist of 28five members, all citizens and residents of the state of Kansas appointed as 29follows: Three members shall be naturopathic doctors appointed by the 30state board of healing arts; one member shall be the president of the state 31board of healing arts or a person designated by the president; and one 32member appointed by the governor shall be from the public sector who is 33not engaged, directly or indirectly, in the provision of health services. 34Insofar as possible persons appointed to the council shall be from different 35geographic areas. If a vacancy occurs on the council, the appointing 36authority of the position which that has become vacant shall appoint a 37person of like qualifications to fill the vacant position for the unexpired 38term, if any. The members of the council appointed by the governor shall 39be appointed for terms of three years and until a successor is appointed. 40The members appointed by the state board of healing arts shall serve at the 41pleasure of the state board of healing arts. If a member is designated by the 42president of the state board of healing arts, the member shall serve at the 43pleasure of the president.1(b) Members of the council attending meetings of the council, or 2attending a subcommittee meeting thereof authorized by the council, shall 3be paid amounts provided in subsection (e) of K.S.A. 75-3223(e), and 4amendments thereto, from the healing arts fee fund.5(c) During the 2003 regular session of the legislature the legislature 6shall consider establishing an alternative health care board composed of 7representatives as may be designated from existing health care regulatory 8agencies, alternative health care providers and members of the general 9public for purposes of advising the legislature on matters relating to 10alternative health care, administering the naturopathic doctor registration 11act and performing such other duties as may be established by law.12(d) The provisions of this section shall take effect on and after 13January 1, 2003.14Sec. 14. K.S.A. 65-7201, 65-7207, 65-7208, 65-7209 and 65-7214 15and K.S.A. 2024 Supp. 65-1626, 65-4101 and 65-7202 and K.S.A. 2024 16Supp. are hereby repealed.17Sec. 15. This act shall take effect and be in force from and after its 18publication in the statute book.
search
keyboard_arrow_up
keyboard_arrow_down
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
arrow_upward
Top
Kansas State Legislature
In-State: 1-800-432-3924
Out-of-State: 785-296-2149
Keywords
Enter any words to search bills, statutes, and documents.
water quality funding
Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611
Statute Number
68-102 72-3715
Exact Phrase
Wrap your query in quotes.
“rules of evidence”
Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget
Searching…
No results found.
search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search- HB 2366›
- HB 2366 — As Introduced
Kansas Legislature
HB 2366 — As Introduced
picture_as_pdf Download PDF Session of 2025HOUSE BILL No. 2366By Committee on Health and Human ServicesRequested by Kevin Barone, Kansas Naturopathic Doctors Association2-71AN ACT concerning health and healthcare; relating to the practice of 2naturopathy; licensure and regulation of naturopathic doctors; 3broadening the scope of practice of naturopathic doctors; amending 4K.S.A. 65-7201, 65-7207, 65-7208, 65-7209 and 65-7214 and K.S.A. 52022 Supp. 65-1626, 65-4101 and 65-7202 and repealing the existing 6sections.78Be it enacted by the Legislature of the State of Kansas:9New Section 1. (a) A naturopathic doctor may:10(1) Order and perform physical examinations, orifical examinations, 11excluding endoscopies, and laboratory examinations for diagnostic 12purposes, including, but not limited to, phlebotomy, clinical laboratory 13tests, speculum examinations and physiological function tests;14(2) order diagnostic imaging studies, including, but not limited to, x-15ray, ultrasound, mammogram, bone densitometry, computed tomography, 16magnetic resonance imaging and electrocardiograms, but a naturopathic 17doctor shall refer patients to an appropriately licensed and qualified 18healthcare professional to conduct diagnostic imaging studies and interpret 19the results;20(3) prescribe, recommend or administer: (A) Food, food extracts, 21nutraceuticals, vitamins, minerals, amino acids, enzymes, whole gland 22thyroid, botanicals, homeopathic preparations, plant substances, dietary 23supplements and nonprescription drugs; (B) human cellular and tissue-24based products that are not regulated as drugs; (C) healthcare and 25nutritional counseling, including fertility counseling; (D) dietary therapy, 26naturopathic physical applications, barrier contraceptive devices and 27intrauterine insemination; (E) substances authorized for intradermal, 28subcutaneous, intramuscular, intravenous, ligamentous, tendinous, 29periarticular or intra-articular administration, including proliferative 30therapy; (F) biofeedback and neurofeedback therapies; and (G) durable 31medical equipment and devices;32(4) prescribe, administer or dispense: (A) Prescription-only drugs as 33defined in K.S.A. 65-1626, and amendments thereto; and (B) testosterone, 34as designated in K.S.A. 65-4109(f)(62), and amendments thereto;35(5) perform minor office procedures and naturopathic acupuncture;1(6) provide naturopathic care to a pregnant patient;2(7) utilize routes of administration that include oral, nasal, topical, 3auricular, ocular, rectal, vaginal, transdermal, intradermal, subcutaneous, 4intramuscular, ligamentous, tendinous, periarticular, intra-articular and 5intravenous; and6(8) utilize non-diagnostic ultrasound in the performance of services.7(b) A naturopathic doctor shall not:8(1) Perform surgery;9(2) perform labor, delivery or any procedure involving the 10reproductive organs of a pregnant patient;11(3) administer ionizing radiation for therapeutic purposes;12(4) use general or spinal anesthetics;13(5) administer, conduct or interpret the results of diagnostic imaging 14studies except as authorized by this act;15(6) claim to practice any licensed healthcare profession or system 16other than naturopathic medicine, unless holding a separate license in that 17profession;18(7) perform procedures involving the termination of a pregnancy; or19(8) prescribe, administer or dispense any controlled substances not 20authorized by this act.21New Sec. 2. A naturopathic doctor who prescribes pursuant to section 221(a)(3) and (a)(4), and amendments thereto, shall:23(a) Record each prescription order in writing, which may include an 24electronically recorded and transmitted communication. The order shall 25include the name, address and telephone number of the naturopathic 26doctor;27(b) prescribe only when the naturopathic doctor has adequate 28education, training and experience to safely manage the medical regimen; 29and30(c) register with the United States drug enforcement administration in 31order to prescribe controlled substances authorized by this act.32New Sec. 3. (a) The practice of naturopathy shall not include the 33following:34(1) Persons whose professional services are performed under the 35supervision or by order of or referral from a naturopathic doctor licensed 36under the naturopathic doctor licensure act;37(2) persons licensed to engage in the practice of naturopathic 38medicine in another state, territory or the District of Columbia when called 39into this state in consultation with naturopathic doctors licensed in this 40state; and41(3) practitioners of the healing arts licensed under the healing arts act 42and practicing their professions or persons performing services pursuant to 43the delegation of a licensee under K.S.A. 65-2872(g), and amendments 1thereto.2(b) Nothing in this act shall be construed to restrict any person 3licensed or regulated by the state of Kansas from engaging in the 4profession or practice for which they are licensed or regulated.5New Sec. 4. (a) Every naturopathic doctor shall maintain a record for 6each patient for whom a professional service is rendered, including: 7Documentation of dates of professional services, pertinent and significant 8information regarding the patient's condition, examinations and testing, all 9findings and results, diagnosis and treatment performed or recommended, 10patient progress and all patient records received from other providers.11(b) Every naturopathic doctor shall maintain a patient's record for a 12minimum of 10 years from the date the licensee provided the professional 13service recorded.14New Sec. 5. If any provision of the naturopathic doctor licensure act 15or application thereof to any person or circumstance is held invalid, such 16invalidity shall not affect other provisions or applications that can be given 17effect without the invalid provision or application, and to this end, the 18provisions of the naturopathic doctor licensure act are declared to be 19severable.20Sec. 6. K.S.A. 2024 Supp. 65-1626 is hereby amended to read as 21follows: 65-1626. As used in the pharmacy act of the state of Kansas:22(a) "Address" means, with respect to prescriptions, the physical 23address where a patient resides, including street address, city and state.24(b) "Administer" means the direct application of a drug, whether by 25injection, inhalation, ingestion or any other means, to the body of a patient 26or research subject by:27(1) A practitioner or pursuant to the lawful direction of a practitioner;28(2) the patient or research subject at the direction and in the presence 29of the practitioner; or30(3) a pharmacist as authorized in K.S.A. 65-1635a, and amendments 31thereto, or K.S.A. 2024 Supp. 65-16,129, and amendments thereto.32(c) "Agent" means an authorized person who acts on behalf of or at 33the direction of a manufacturer, repackager, wholesale distributor, third-34party logistics provider or dispenser but does not include a common 35carrier, public warehouseman or employee of the carrier or warehouseman 36when acting in the usual and lawful course of the carrier's or 37warehouseman's business.38(d) "Automated dispensing system" means a robotic or mechanical 39system controlled by a computer that:40(1) Performs operations or activities, other than compounding or 41administration, relative to the storage, packaging, labeling, dispensing or 42distribution of drugs;43(2) collects, controls and maintains all transaction information; and1(3) operates in accordance with the board's rules and regulations.2(e) "Biological product" means the same as defined in 42 U.S.C. § 3262(i), as in effect on January 1, 2017.4(f) "Board" means the state board of pharmacy created by K.S.A. 74-51603, and amendments thereto.6(g) "Brand exchange," in the case of a drug prescribed, means the 7dispensing of a different drug product of the same dosage form and 8strength and of the same generic name as the brand name drug product 9prescribed, and in the case of a biological product prescribed, means the 10dispensing of an interchangeable biological product.11(h) "Brand name" means the registered trademark name given to a 12drug product by its manufacturer, labeler or distributor.13(i) "Co-licensed partner" means a person or pharmaceutical 14manufacturer that has entered into an agreement with another 15pharmaceutical manufacturer or an affiliate of the manufacturer to engage 16in a business activity or occupation related to the manufacture or 17distribution of a product.18(j) "Common carrier" means any person who undertakes, whether 19directly or by any other arrangement, to transport property, including 20drugs, for compensation.21(k) (1) "Compounding" means the combining of components into a 22compounded preparation under either of the following conditions:23(A) As the result of a practitioner's prescription drug order or 24initiative based on the practitioner-patient-pharmacist relationship in the 25course of professional practice to meet the specialized medical need of an 26individual patient of the practitioner that cannot be filled by an FDA-27approved drug; or28(B) for the purpose of, or incidental to, research, teaching or chemical 29analysis, and not for sale or dispensing.30(2) Compounding includes the preparation of drugs or devices in 31anticipation of receiving prescription drug orders based on routine, 32regularly observed prescribing patterns.33(3) Compounding does not include reconstituting any mixed drug 34according to the FDA-approved labeling for the drug.35(l) "Current good manufacturing practices" or "CGMP" means the 36requirements for ensuring that drugs and drug products are consistently 37manufactured, repackaged, produced, stored and dispensed in accordance 38with 21 C.F.R. §§ 207, 210 and 211.39(m) "DEA" means the United States department of justice, drug 40enforcement administration.41(n) "Deliver" or "delivery" means the actual, constructive or 42attempted transfer from one person to another of any drug whether or not 43an agency relationship exists.1(o) "Device" means an instrument, apparatus, implement, machine, 2contrivance, implant, in vitro reagent or other similar or related article, 3including a component part or accessory that:4(1) (A) Is recognized in the official national formulary, or the United 5States pharmacopoeia, or any supplement thereof;6(B) is intended for use in the diagnosis of disease or other conditions;7(C) is used for the cure, mitigation, treatment or prevention of disease 8in human or other animals; or9(D) is intended to affect the structure or any function of the body of 10human or other animals; and11(2) (A) does not achieve its primary intended purposes through 12chemical action within or on the body of human or other animals; and13(B) is not dependent upon being metabolized for the achievement of 14any of its primary intended purposes.15(p) "Direct supervision" means the process by which the responsible 16pharmacist shall observe and direct the activities of a pharmacist intern or 17pharmacy technician, be readily and immediately available at all time 18activities are performed, provide personal assistance, direction and 19approval throughout the time the activities are performed and complete the 20final check before dispensing.21(q) "Dispense" or "dispensing" means to deliver prescription 22medication to the ultimate user or research subject by or pursuant to the 23lawful order of a practitioner or pursuant to the prescription of a mid-level 24practitioner, including, but not limited to, delivering prescription 25medication to a patient by mail, common carrier, personal delivery or 26third-party delivery to any location requested by the patient.27(r) "Dispenser" means:28(1) A practitioner or pharmacist who dispenses prescription drugs or 29devices or a physician assistant who has authority to dispense prescription-30only drugs in accordance with K.S.A. 65-28a08(b), and amendments 31thereto; or32(2) a retail pharmacy, hospital pharmacy or group of pharmacies 33under common ownership and control that do not act as a wholesale 34distributor.35(s) "Distribute" or "distribution" means to deliver, offer to deliver, 36sell, offer to sell, purchase, trade, transfer, broker, give away, handle, store 37or receive, other than by administering or dispensing, any product, but 38does not include dispensing a product pursuant to a prescription executed 39in accordance with 21 U.S.C. § 353 or the dispensing of a product 40approved under 21 U.S.C. § 360b.41(t) "Distributor" means a person or entity that distributes a drug or 42device.43(u) "Diversion" means the transfer of a controlled substance from a 1lawful to an unlawful channel of distribution or use.2(v) "Drop shipment" means the sale, by a manufacturer, repackager or 3exclusive distributor, of the manufacturer's prescription drug to a 4wholesale distributor whereby the wholesale distributor takes title but not 5possession of such prescription drug and the wholesale distributor invoices 6the dispenser, and the dispenser receives delivery of the prescription drug 7directly from the manufacturer, repackager, third-party logistics provider 8or exclusive distributor, of such prescription drug.9(w) "Drug" means articles:10(1) Recognized in the official United States pharmacopeia, or other 11such official compendiums of the United States, or official national 12formulary, or any supplement to any of them;13(2) intended for use in the diagnosis, cure, mitigation, treatment or 14prevention of disease in human or other animals;15(3) other than food, intended to affect the structure or any function of 16the body of human or other animals; and17(4) intended for use as a component of any articles specified in 18paragraph (1), (2) or (3); but does not include devices or their components, 19parts or accessories, except that the term "drug" does not include 20amygdalin (laetrile) or any livestock remedy, if such livestock remedy had 21been registered in accordance with the provisions of article 5 of chapter 47 22of the Kansas Statutes Annotated, prior to its repeal.23(x) "Durable medical equipment" means equipment that:24(1) Provides therapeutic benefits or enables an individual to perform 25certain tasks that the individual is unable to otherwise undertake due to 26certain medical conditions or illnesses;27(2) is primarily and customarily used to serve a medical purpose;28(3) generally is not useful to a person in the absence of an illness or 29injury;30(4) can withstand repeated use;31(5) is appropriate for use in the home, long-term care facility or 32medical care facility, but may be transported to other locations to allow the 33individual to complete instrumental activities of daily living that are more 34complex tasks required for independent living; and35(6) may include devices and medical supplies or other similar 36equipment determined by the board in rules and regulations adopted by the 37board.38(y) "Electronic prescription" means an electronically prepared 39prescription that is authorized and transmitted from the prescriber to the 40pharmacy by means of electronic transmission.41(z) "Electronic prescription application" means software that is used 42to create electronic prescriptions and that is intended to be installed on the 43prescriber's computers and servers where access and records are controlled 1by the prescriber.2(aa) "Electronic signature" means a confidential personalized digital 3key, code, number or other method for secure electronic data transmissions 4that identifies a particular person as the source of the message, 5authenticates the signatory of the message and indicates the person's 6approval of the information contained in the transmission.7(bb) "Electronic transmission" means the transmission of an 8electronic prescription, formatted as an electronic data file, from a 9prescriber's electronic prescription application to a pharmacy's computer, 10where the data file is imported into the pharmacy prescription application.11(cc) "Electronically prepared prescription" means a prescription that 12is generated using an electronic prescription application.13(dd) "Exclusive distributor" means the wholesale distributor that 14directly purchased the product from the manufacturer and is the sole 15distributor of that manufacturer's product to a subsequent repackager, 16wholesale distributor or dispenser.17(ee) "FDA" means the United States department of health and human 18services, food and drug administration.19(ff) "Facsimile transmission" or "fax transmission" means the 20transmission of a digital image of a prescription from the prescriber or the 21prescriber's agent to the pharmacy. "Facsimile transmission" includes, but 22is not limited to, transmission of a written prescription between the 23prescriber's fax machine and the pharmacy's fax machine; transmission of 24an electronically prepared prescription from the prescriber's electronic 25prescription application to the pharmacy's fax machine, computer or 26printer; or transmission of an electronically prepared prescription from the 27prescriber's fax machine to the pharmacy's fax machine, computer or 28printer.29(gg) "Generic name" means the established chemical name or official 30name of a drug or drug product.31(hh) "Healthcare entity" means any person that provides diagnostic, 32medical, surgical or dental treatment or rehabilitative care but does not 33include any retail pharmacy or wholesale distributor.34(ii) (1) "Institutional drug room" means any location where 35prescription-only drugs are stored and from which prescription-only drugs 36are administered or dispensed and that is maintained or operated for the 37purpose of providing the drug needs of:38(A) Inmates of a jail or correctional institution or facility;39(B) residents of a juvenile correctional facility or juvenile detention 40facility, as defined in K.S.A. 38-2302, and amendments thereto;41(C) students of a public or private university or college, a community 42college or any other institution of higher learning that is located in Kansas;43(D) employees of a business or other employer; or1(E) persons receiving inpatient hospice services.2(2) "Institutional drug room" does not include:3(A) Any registered pharmacy;4(B) any office of a practitioner; or5(C) a location where no prescription-only drugs are dispensed and no 6prescription-only drugs other than individual prescriptions are stored or 7administered.8(jj) "Interchangeable biological product" means a biological product 9that the FDA has identified in the "purple book: lists of licensed biological 10products with reference product exclusivity and biosimilarity or 11interchangeability evaluations" as meeting the standards for 12"interchangeability" as defined in 42 U.S.C. § 262(k), as in effect on 13January 1, 2017.14(kk) "Intracompany transaction" means any transaction or transfer 15between any division, subsidiary, parent or affiliated or related company 16under common ownership or control of a corporate entity, or any 17transaction or transfer between co-licensed partners.18(ll) "Label" means a display of written, printed or graphic matter 19upon the immediate container of any drug.20(mm) "Labeling" means the process of preparing and affixing a label 21to any drug container, exclusive of the labeling by a manufacturer, packer 22or distributor of a non-prescription drug or commercially packaged legend 23drug.24(nn) "Fingerprint candidate" means a person who has made an 25original application for or reinstatement of any license, registration, permit 26or certificate under this act or a person who currently holds a license, 27registration, permit or certificate under this act.28(oo) "Long-term care facility" means "nursing facility," as defined in 29K.S.A. 39-923, and amendments thereto.30(pp) "Medical care facility" means the same as defined in K.S.A. 65-31425, and amendments thereto, and also includes psychiatric hospitals and 32psychiatric residential treatment facilities as defined by K.S.A. 39-2002, 33and amendments thereto.34(qq) "Manufacture" means the production, preparation, propagation, 35compounding, conversion or processing of a drug either directly or 36indirectly by extraction from substances of natural origin, independently 37by means of chemical or biological synthesis or by a combination of 38extraction and chemical or biological synthesis or the packaging or 39repackaging of the drug or labeling or relabeling of its container, except 40that this term does not include the preparation or compounding of a drug 41by an individual for the individual's own use or the preparation, 42compounding, packaging or labeling of a drug by:43(1) A practitioner or a practitioner's authorized agent incident to such 1practitioner's administering or dispensing of a drug in the course of the 2practitioner's professional practice;3(2) a practitioner, by a practitioner's authorized agent or under a 4practitioner's supervision for the purpose of, or as an incident to, research, 5teaching or chemical analysis and not for sale; or6(3) a pharmacist or the pharmacist's authorized agent acting under the 7direct supervision of the pharmacist for the purpose of, or incident to, the 8dispensing of a drug by the pharmacist.9(rr) "Manufacturer" means:10(1) A person that holds an application approved under section 505 of 11the federal food, drug and cosmetic act or a license issued under section 12351 of the federal public health service act for such drug or, if such drug is 13not the subject of an approved application or license, the person who 14manufactured the drug;15(2) a co-licensed partner of the person described in paragraph (1) that 16obtains the drug directly from a person described in paragraph (1) or (3); 17or18(3) an affiliate of a person described in paragraph (1) or (2) that 19receives the product directly from a person described in paragraph (1) or 20(2).21(ss) "Medication order" means a written or oral order by a prescriber 22or the prescriber's authorized agent for administration of a drug or device 23to a patient in a Kansas licensed medical care facility or in a Kansas 24licensed nursing facility or nursing facility for mental health, as such terms 25are defined by K.S.A. 39-923, and amendments thereto.26(tt) "Mid-level practitioner" means a certified nurse-midwife 27engaging in the independent practice of midwifery under the independent 28practice of midwifery act, an advanced practice registered nurse issued a 29license pursuant to K.S.A. 65-1131, and amendments thereto, who has 30authority to prescribe drugs under K.S.A. 65-1130, and amendments 31thereto, or a physician assistant licensed pursuant to the physician assistant 32licensure act who has authority to prescribe drugs pursuant to a written 33agreement with a supervising physician under K.S.A. 65-28a08, and 34amendments thereto.35(uu) "Nonresident pharmacy" means a pharmacy located outside of 36Kansas.37(vv) "Outsourcing facility" means a facility at one geographic 38location or address that is engaged in the compounding of sterile drugs and 39has registered with the FDA as an outsourcing facility pursuant to 21 40U.S.C. § 353b.41(ww) "Person" means individual, corporation, government, 42governmental subdivision or agency, partnership, association or any other 43legal entity.1(xx) "Pharmacist" means any natural person licensed under this act to 2practice pharmacy.3(yy) "Pharmacist-in-charge" means the pharmacist who is responsible 4to the board for a registered establishment's compliance with the laws and 5regulations of this state pertaining to the practice of pharmacy, 6manufacturing of drugs and the distribution of drugs. The pharmacist-in-7charge shall supervise such establishment on a full-time or a part-time 8basis and perform such other duties relating to supervision of a registered 9establishment as may be prescribed by the board by rules and regulations. 10Nothing in this definition shall relieve other pharmacists or persons from 11their responsibility to comply with state and federal laws and regulations.12(zz) "Pharmacist intern" or "intern" means:13(1) A student currently enrolled in and in good standing with an 14accredited pharmacy program;15(2) a graduate of an accredited pharmacy program serving an 16internship; or17(3) a graduate of a pharmacy program located outside of the United 18States that is not accredited and who has successfully passed equivalency 19examinations approved by the board.20(aaa) "Pharmacy," "drugstore" or "apothecary" means premises, 21laboratory, area or other place, including any electronic medium:22(1) Where drugs are offered for sale where the profession of 23pharmacy is practiced and where prescriptions are compounded and 24dispensed;25(2) that has displayed upon it or within it the words "pharmacist," 26"pharmaceutical chemist," "pharmacy," "apothecary," "drugstore," 27"druggist," "drugs," "drug sundries" or any of these words or combinations 28of these words or words of similar import in any language or on any sign 29containing any of these words as used in the context of health, medical or 30pharmaceutical care or services; or31(3) where the characteristic symbols of pharmacy or the characteristic 32prescription sign "Rx" may be exhibited in the context of health, medical 33or pharmaceutical care or services. As used in this subsection, premises 34refers only to the portion of any building or structure leased, used or 35controlled by the licensee in the conduct of the business registered by the 36board at the address for which the registration was issued.37(bbb) "Pharmacy prescription application" means software that is 38used to process prescription information and is either installed on a 39pharmacy's computers or servers and is controlled by the pharmacy or is 40maintained on the servers of an entity that sells electronic pharmacy 41prescription applications as a hosted service where the entity controls 42access to the application and maintains the software and records on its 43server.1(ccc) "Pharmacy technician" means an individual who, under the 2direct supervision and control of a pharmacist, may perform packaging, 3manipulative, repetitive or other nondiscretionary tasks related to the 4processing of a prescription or medication order and who assists the 5pharmacist in the performance of pharmacy-related duties, but who does 6not perform duties restricted to a pharmacist.7(ddd) "Practitioner" means a person licensed to practice medicine and 8surgery, dentist, podiatrist, veterinarian, optometrist, naturopathic doctor 9or scientific investigator or other person authorized by law to use a 10prescription-only drug in teaching or chemical analysis or to conduct 11research with respect to a prescription-only drug.12(eee) "Preceptor" means a licensed pharmacist who possesses at least 13two years' experience as a pharmacist and who supervises and is 14responsible for the actions of pharmacist interns obtaining pharmaceutical 15experience.16(fff) "Prescriber" means a practitioner or a mid-level practitioner.17(ggg) "Prescription" or "prescription order" means the front and back 18of a lawful written, electronic or facsimile order from a prescriber or an 19oral order from a prescriber or the prescriber's authorized agent that 20communicates the prescriber's instructions for a prescription drug or 21device to be dispensed.22(hhh) "Prescription medication" means any drug, including label and 23container according to context, that is dispensed pursuant to a prescription 24order.25(iii) "Prescription-only drug" means any drug whether intended for 26use by human or animal, required by federal or state law, including 21 27U.S.C. § 353, to be dispensed only pursuant to a written or oral 28prescription or order of a practitioner or is restricted to use by practitioners 29only.30(jjj) "Probation" means the practice or operation under a temporary 31license, registration or permit or a conditional license, registration or 32permit of a business or profession for which a license, registration or 33permit is granted by the board under the provisions of the pharmacy act of 34the state of Kansas requiring certain actions to be accomplished or certain 35actions not to occur before a regular license, registration or permit is 36issued.37(lll) "Product" means the same as defined by part H of the federal 38drug supply chain security act, 21 U.S.C. § 351 et seq. and 21 U.S.C. § 39360eee.40(mmm) "Professional incompetency" means:41(1) One or more instances involving failure to adhere to the 42applicable standard of pharmaceutical care to a degree that constitutes 43gross negligence, as determined by the board;1(2) repeated instances involving failure to adhere to the applicable 2standard of pharmaceutical care to a degree that constitutes ordinary 3negligence, as determined by the board; or4(3) a pattern of pharmacy practice or other behavior that demonstrates 5a manifest incapacity or incompetence to practice pharmacy.6(nnn) "Readily retrievable" or "readily available" means that records 7kept in hard copy or by automatic data processing applications or other 8electronic or mechanized record-keeping systems can be separated out 9from all other records quickly and easily during an inspection or 10investigation, or within a reasonable time not to exceed 48 hours of a 11written request from the board or other authorized agent.12(ooo) "Repackage" means changing the container, wrapper, quantity 13or label of a drug to further the distribution of the drug.14(ppp) "Repackager" means a person who owns or operates a facility 15that repackages.16(qqq) "Retail dealer" means a person selling at retail nonprescription 17drugs that are prepackaged, fully prepared by the manufacturer or 18distributor for use by the consumer and labeled in accordance with the 19requirements of the state and federal food, drug and cosmetic acts. Such 20nonprescription drugs shall not include: (1) A controlled substance; (2) a 21prescription-only drug; or (3) a drug intended for human use by 22hypodermic injection.23(rrr) "Reverse distributor" means a person who owns or operates an 24establishment that disposes of or otherwise processes saleable or 25nonsaleable products received from an authorized trading partner such that 26the product may be processed for credit to the purchaser, manufacturer or 27seller or disposed of for no further distribution.28(sss) "Secretary" means the executive secretary of the board.29(ttt) "Third-party logistics provider" means an entity that provides or 30coordinates warehousing or other logistic services of a product in interstate 31commerce on behalf of a manufacturer, wholesale distributor or dispenser, 32but does not take ownership of the product or have responsibility to direct 33the sale or disposition of the product.34(uuu) "Trading partner" means:35(1) A manufacturer, repackager, wholesale distributor or dispenser 36from whom a manufacturer, repackager, wholesale distributor or dispenser 37accepts direct ownership of a product or to whom a manufacturer, 38repackager, wholesale distributor or dispenser transfers direct ownership of 39a product; or40(2) a third-party logistics provider from whom a manufacturer, 41repackager, wholesale distributor or dispenser accepts direct possession of 42a product or to whom a manufacturer, repackager, wholesale distributor or 43dispenser transfers direct possession of a product.1(vvv) "Transaction" means the transfer of product between persons in 2which a change of ownership occurs.3(www) "Unprofessional conduct" means:4(1) Fraud in securing a registration or permit;5(2) intentional adulteration or mislabeling of any drug, medicine, 6chemical or poison;7(3) causing any drug, medicine, chemical or poison to be adulterated 8or mislabeled, knowing the same to be adulterated or mislabeled;9(4) intentionally falsifying or altering records or prescriptions;10(5) unlawful possession of drugs and unlawful diversion of drugs to 11others;12(6) willful betrayal of confidential information under K.S.A. 65-1654, 13and amendments thereto;14(7) conduct likely to deceive, defraud or harm the public;15(8) making a false or misleading statement regarding the licensee's 16professional practice or the efficacy or value of a drug;17(9) commission of any act of sexual abuse, misconduct or 18exploitation related to the licensee's professional practice; or19(10) performing unnecessary tests, examinations or services that have 20no legitimate pharmaceutical purpose.21(xxx) "Vaccination protocol" means a written protocol, agreed to and 22signed by a pharmacist and a person licensed to practice medicine and 23surgery by the state board of healing arts, that establishes procedures and 24recordkeeping and reporting requirements for administering a vaccine by 25the pharmacist for a period of time specified therein, not to exceed two 26years.27(yyy) "Valid prescription order" means a prescription that is issued 28for a legitimate medical purpose by an individual prescriber licensed by 29law to administer and prescribe drugs and acting in the usual course of 30such prescriber's professional practice. A prescription issued solely on the 31basis of an internet-based questionnaire or consultation without an 32appropriate prescriber-patient relationship is not a valid prescription order.33(zzz) "Veterinary medical teaching hospital pharmacy" means any 34location where prescription-only drugs are stored as part of an accredited 35college of veterinary medicine and from which prescription-only drugs are 36distributed for use in treatment of or administration to a nonhuman.37(aaaa) "Virtual manufacturer" means an entity that engages in the 38manufacture of a drug or device for which it:39(1) Owns the new drug application or abbreviated new drug 40application number, if a prescription drug;41(2) owns the unique device identification number, as available, for a 42prescription device;43(3) contracts with a contract manufacturing organization for the 1physical manufacture of the drug or device;2(4) is not involved in the physical manufacture of the drug or device; 3and4(5) does not store or take physical possession of the drug or device.5(bbbb) "Virtual wholesale distributor" means a wholesale distributor 6that sells, brokers or transfers a drug or device but never physically 7possesses the product.8(cccc) "Wholesale distributor" means any person engaged in 9wholesale distribution or reverse distribution of drugs or devices, other 10than a manufacturer, co-licensed partner or third-party logistics provider.11(dddd) "Wholesale distribution" means the distribution or receipt of 12drugs or devices to or by persons other than consumers or patients, in 13which a change of ownership occurs. "Wholesale distribution" does not 14include:15(1) The dispensing of a drug or device pursuant to a prescription;16(2) the distribution of a drug or device or an offer to distribute a drug 17or device for emergency medical reasons, including a public health 18emergency declaration pursuant to section 319 of the public health service 19act, except that, for purposes of this paragraph, a drug or device shortage 20not caused by a public health emergency shall not constitute an emergency 21medical reason;22(3) intracompany distribution;23(4) the distribution of a drug or device, or an offer to distribute a drug 24or device, among hospitals or other healthcare entities under common 25control;26(5) the distribution of a drug or device, or the offer to distribute a 27drug or device, by a charitable organization described in section 501(c)(3) 28of the internal revenue code of 1986 to a nonprofit affiliate of the 29organization to the extent otherwise permitted by law;30(6) the distribution of an intravenous drug used to maintain the 31equilibrium of water and minerals in the body, such as dialysis solutions; 32or33(7) the sale or transfer from a retail pharmacy of expired, damaged, 34returned or recalled prescription drugs to the original manufacturer, 35originating wholesale distributor or to a reverse distributor registered in 36accordance with the board's rules and regulations.37Sec. 7. K.S.A. 2022 Supp. 65-4101 is hereby amended to read as 38follows: 65-4101. As used in this act:39(a) "Administer" means the direct application of a controlled 40substance, whether by injection, inhalation, ingestion or any other means, 41to the body of a patient or research subject by:42(1) A practitioner or pursuant to the lawful direction of a practitioner; 43or1(2) the patient or research subject at the direction and in the presence 2of the practitioner.3(b) "Agent" means an authorized person who acts on behalf of or at 4the direction of a manufacturer, distributor or dispenser. It does not include 5a common carrier, public warehouseman or employee of the carrier or 6warehouseman.7(c) "Application service provider" means an entity that sells 8electronic prescription or pharmacy prescription applications as a hosted 9service where the entity controls access to the application and maintains 10the software and records on its server.11(d) "Board" means the state board of pharmacy.12(e) "Bureau" means the bureau of narcotics and dangerous drugs, 13United States department of justice, or its successor agency.14(f) "Controlled substance" means any drug, substance or immediate 15precursor included in any of the schedules designated in K.S.A. 65-4105, 1665-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.17(g) (1) "Controlled substance analog" means a substance that is 18intended for human consumption, and at least one of the following:19(A) The chemical structure of the substance is substantially similar to 20the chemical structure of a controlled substance listed in or added to the 21schedules designated in K.S.A. 65-4105 or 65-4107, and amendments 22thereto;23(B) the substance has a stimulant, depressant or hallucinogenic effect 24on the central nervous system substantially similar to the stimulant, 25depressant or hallucinogenic effect on the central nervous system of a 26controlled substance included in the schedules designated in K.S.A. 65-274105 or 65-4107, and amendments thereto; or28(C) with respect to a particular individual, such individual represents 29or intends the substance to have a stimulant, depressant or hallucinogenic 30effect on the central nervous system substantially similar to the stimulant, 31depressant or hallucinogenic effect on the central nervous system of a 32controlled substance included in the schedules designated in K.S.A. 65-334105 or 65-4107, and amendments thereto.34(2) "Controlled substance analog" does not include:35(A) A controlled substance;36(B) a substance for which there is an approved new drug application; 37or38(C) a substance with respect to which an exemption is in effect for 39investigational use by a particular person under section 505 of the federal 40food, drug and cosmetic act, 21 U.S.C. § 355, to the extent conduct with 41respect to the substance is permitted by the exemption.42(h) "Counterfeit substance" means a controlled substance that, or the 43container or labeling of which, without authorization bears the trademark, 1trade name or other identifying mark, imprint, number or device or any 2likeness thereof of a manufacturer, distributor or dispenser other than the 3person who in fact manufactured, distributed or dispensed the substance.4(i) "Cultivate" means the planting or promotion of growth of five or 5more plants that contain or can produce controlled substances.6(j) "DEA" means the300 SW 10th Ave, Topeka, KS 66612
Ad Astra Per Aspera
Kansas Legislative HotlineIn-State: 1-800-432-3924
Out-of-State: 785-296-2149
Government
- Legislators
- House
- Representatives
- Senate
- Senators
- Committees
Resources
- Bills & Measures
- Today
- Live
- Journals
- Calendars
- Archived Records
- Laws
- Search
- RSS Feeds
Support
- Contact Us
- Accessibility
- Privacy Policy
- Visit Us
Texto oficial de la Legislatura de Kansas. El formato se adaptó para leerlo en Ratifi.